Characterization of the activity of α/β-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compound
- 1 September 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (9) , 1187-1191
- https://doi.org/10.1016/0277-5379(84)90128-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Chemosensitivity of human melanoma xenografts in immunocompetent mice and its histological evaluationInternational Journal of Cancer, 1984
- Phase I clinical trial with alpha 1,3,5-triglycidyl-s-triazinetrione (NSC-296934)European Journal of Cancer and Clinical Oncology, 1981
- Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-S-triazinetrione (NSC 296934)Published by Elsevier ,1980
- A characterization of the activity of ?-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compoundCancer Chemotherapy and Pharmacology, 1980
- The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcomaPublished by Elsevier ,1975